Risiko
Bærekraft
🌳
🌳
🌳
(1 av 3)
Pris
0,25%
The investment objective of the Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the S&P 500 Capped 35/20 Health Care Index. In order to achieve this investment objective, the investment policy of the Fund is to invest in a portfolio of equity securities that as far as possible and practicable consist of the component securities of the S&P 500 Capped 35/20 Health Care Index, this Fund’s Benchmark Index. The Fund intends to replicate the constituents of the Benchmark Index by holding all the securities comprising the Benchmark Index in a similar proportion to their weightings in the Benchmark Index. In order to replicate its Benchmark Index, this Fund may invest up to 20% of its Net Asset Value in shares issued by the same body. This limit may be raised to 35% for a single issuer when exceptional market conditions apply (as set out in section 4 of Schedule III).
10 største eierandeler
Eli Lilly and Co
12,9%
UnitedHealth Group Inc
9,6%
Johnson & Johnson
7,1%
AbbVie Inc
6,1%
Merck & Co Inc
4,8%
Thermo Fisher Scientific Inc
3,9%
Abbott Laboratories
3,6%
Intuitive Surgical Inc
3,3%
Amgen Inc
3,1%
Pfizer Inc
2,9%
Helse
100,0%
Nord-Amerika
100,0%
Totalpris (det du betaler årlig):
0,25%
Prisdetaljer
Pris for fondet:
0,15%
Plattformavgift:
0,10%
Vis priser med rabatt for Akademikerne Pluss eller Tekna
Avkastning pr. 28.10
Siste måned:
1,0%
Siste 6 måneder:
6,6%
Hittil i år:
19,1%
Siste år:
20,0%
Siste 3 år (per år):
15,5%
Siste 5 år (per år):
15,5%
Morningstar-rating:
5
ISIN:
IE00B43HR379
Forvaltningskapital:
30 757 043 288 kr
Kategori:
Bransjefond, Helsevern
NAV/Kurs (28.10.2024):
129 kr
Obligasjoner:
0,0%
Kontanter:
0,3%
Aksjer:
99,8%
Annet:
0,0%
Startdato:
20.11.2015